US20140135817A1 - Left atrial appendage closure implant - Google Patents
Left atrial appendage closure implant Download PDFInfo
- Publication number
- US20140135817A1 US20140135817A1 US14/057,573 US201314057573A US2014135817A1 US 20140135817 A1 US20140135817 A1 US 20140135817A1 US 201314057573 A US201314057573 A US 201314057573A US 2014135817 A1 US2014135817 A1 US 2014135817A1
- Authority
- US
- United States
- Prior art keywords
- bend
- atrial appendage
- left atrial
- support frame
- row
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12122—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder within the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00526—Methods of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00601—Implements entirely comprised between the two sides of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00632—Occluding a cavity, i.e. closing a blind opening
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
Definitions
- the disclosure relates generally to percutaneous medical devices and more particularly to percutaneous medical devices for implantation into the left atrial appendage (LAA) of a heart.
- LAA left atrial appendage
- Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting over 5.5 million people worldwide. Atrial fibrillation is the irregular, chaotic beating of the upper chambers of the heart. Electrical impulses discharge so rapidly that the atrial muscle quivers, or fibrillates. Episodes of atrial fibrillation may last a few minutes or several days. The most serious consequence of atrial fibrillation is ischemic stroke. It has been estimated that up to 20% of all strokes are related to atrial fibrillation. Most atrial fibrillation patients, regardless of the severity of their symptoms or frequency of episodes, require treatment to reduce the risk of stroke.
- the left atrial appendage is a small organ attached to the left atrium of the heart as a pouch-like extension.
- the left atrial appendage may not properly contract with the left atrium, causing stagnant blood to pool within its interior, which can lead to the undesirable formation of thrombi within the left atrial appendage.
- Thrombi forming in the left atrial appendage may break loose from this area and enter the blood stream.
- Thrombi that migrate through the blood vessels may eventually plug a smaller vessel downstream and thereby contribute to stroke or heart attack.
- Clinical studies have shown that the majority of blood clots in patients with atrial fibrillation are found in the left atrial appendage.
- medical devices have been developed which are positioned in the left atrial appendage and deployed to close off the ostium of the left atrial appendage.
- the exposed surface(s) spanning the ostium of the left atrial appendage becomes covered with tissue (a process called endothelization), effectively removing the left atrial appendage from the circulatory system and reducing or eliminating the amount of thrombi which may enter the blood stream from the left atrial appendage.
- a medical device for left atrial appendage closure may include a delivery catheter having a lumen extending therethrough; and a left atrial appendage closure implant including a proximal collar, a distal collar, and a monolithic support frame extending therebetween, the support frame including: a first bend extending from the proximal collar to a second bend, a first segment extending from the second bend to a third bend, a second segment extending from the third bend to a fourth bend, and a third segment extending from the fourth bend to the distal collar, wherein the support frame is actuatable from a first constrained position to a second flowering position to a third mid-deployment position to a fourth unconstrained position.
- a left atrial appendage closure implant may include a self-expanding support frame having a circumference and a central longitudinal axis, a membrane disposed over at least a portion of the support frame, and a plurality of anchors arranged into a first row and a second row such that the first row and the second row form a staggered pattern about the circumference of the support frame.
- a method of manufacturing a left atrial appendage closure implant may include the steps of:
- FIG. 1 is a schematic partial cross-sectional view of a heart
- FIG. 2 is a schematic partial cross-sectional view of an example left atrial appendage
- FIGS. 3-3A illustrate an example prior art implant
- FIG. 4A is a partial cross-sectional view of the example prior art implant of FIGS. 3-3A in a first, constrained position;
- FIGS. 4B-4D illustrate perspective views of the example prior art implant of FIGS. 3-3A in various stages of deployment
- FIG. 5 illustrates a portion of an example medical device according to the present disclosure
- FIG. 6 is a partial cross-sectional view of the example medical device of FIG. 5 ;
- FIG. 7 is a partial cross-sectional view of the example medical device of FIG. 5 in a first, constrained position
- FIG. 8 illustrates the example medical device of FIG. 5 partially deployed
- FIG. 9 illustrates the example medical device of FIG. 5 partially deployed
- FIG. 10 illustrates the example medical device of FIG. 5 during manufacture in a flat-pattern view
- FIG. 10A is a detailed view of a portion of the example medical device shown in FIG. 10 ;
- FIG. 11 illustrates a portion of the example medical device of FIG. 5 ;
- FIG. 12 is a partial cross-sectional view of the example medical device of FIGS. 5 and 11 deployed within the example left atrial appendage of FIG. 2 .
- upstream and downstream refer to a position or location relative to the direction of blood flow through a particular element or location, such as a vessel (i.e., the aorta), a heart valve (i.e., the aortic valve), and the like.
- a vessel i.e., the aorta
- a heart valve i.e., the aortic valve
- proximal and distal shall generally refer to the relative position, orientation, or direction of an element or action, from the perspective of a clinician using the medical device, relative to one another. While the terms are not meant to be limiting, “proximal” may generally be considered closer to the clinician or an exterior of a patient, and “distal” may generally be considered to be farther away from the clinician, along the length of the medical device.
- monolithic and/or unitary shall generally refer to an element or elements made from or consisting of a single structure or base unit/element.
- a monolithic and/or unitary element shall exclude structure and/or features made by assembling or otherwise joining multiple discrete elements together.
- numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated.
- the term “about”, in the context of numeric values, generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the term “about” may include numbers that are rounded to the nearest significant figure. Other uses of the term “about” (i.e., in a context other than numeric values) may be assumed to have their ordinary and customary definition(s), as understood from and consistent with the context of the specification, unless otherwise specified.
- Weight percent, percent by weight, wt %, wt-%, % by weight, and the like are synonyms that refer to the concentration of a substance as the weight of that substance divided by the weight of the composition and multiplied by 100.
- LAA left atrial appendage
- the occurrence of thrombi in the left atrial appendage (LAA) during atrial fibrillation may be due to stagnancy of the blood pool in the LAA.
- the blood may still be pulled out of the left atrium by the left ventricle, however less effectively due to the irregular contraction of the left atrium caused by atrial fibrillation. Therefore, instead of an active support of the blood flow by a contracting left atrium and left atrial appendage, filling of the left ventricle may depend primarily or solely on the suction effect created by the left ventricle. Further, the contraction of the left atrial appendage may not be in sync with the cycle of the left ventricle.
- contraction of the left atrial appendage may be out of phase up to 180 degrees with the left ventricle, which may create significant resistance to the desired flow of blood.
- most left atrial appendage geometries are complex and highly variable, with large irregular surface areas and a narrow ostium or opening compared to the depth of the left atrial appendage.
- a medical device In an effort to reduce the occurrence of thrombi formation within the left atrial appendage and prevent thrombi from entering the blood stream from within the left atrial appendage, a medical device has been developed that closes off the left atrial appendage from the heart and/or circulatory system, thereby lowering the risk of stroke due to thrombolytic material entering the blood stream from the left atrial appendage.
- FIG. 1 is a partial cross-sectional view of certain elements of a human heart 10 and some immediately adjacent blood vessels.
- a heart 10 may include a left ventricle 12 , a right ventricle 14 , a left atrium 16 , and a right atrium 18 .
- An aortic valve 22 is disposed between the left ventricle 12 and an aorta 20 .
- a pulmonary or semi-lunar valve 26 is disposed between the right ventricle 14 and a pulmonary artery 24 .
- a superior vena cava 28 and an inferior vena cava 30 return blood from the body to the right atrium 18 .
- a mitral valve 32 is disposed between the left atrium 16 and the left ventricle 12 .
- a tricuspid valve 34 is disposed between the right atrium 18 and the right ventricle 14 .
- Pulmonary veins 36 return blood from the lungs to the left atrium 16 .
- a left atrial appendage (LAA) 50 is attached to and in fluid communication with the left atrium 16 .
- FIG. 2 is a partial cross-sectional view of an example left atrial appendage 50 .
- the left atrial appendage 50 may have a complex geometry and/or irregular surface area.
- the illustrated LAA is merely one of many possible shapes and sizes for the LAA, which may vary from patient to patient.
- the medical devices and methods disclosed herein may be adapted for various sizes and shapes of the LAA, as necessary.
- a left atrial appendage 50 may include a generally longitudinal axis 52 arranged along a depth of a main body 60 of the left atrial appendage 50 .
- the main body 60 may include a lateral wall 54 and an ostium 56 forming a proximal mouth 58 .
- a lateral extent of the ostium 56 and/or the lateral wall 54 may be smaller or less than a depth of the main body 60 along the longitudinal axis 52 , or a depth of the main body 60 may be greater than a lateral extent of the ostium 56 and/or the lateral wall 54 .
- the left atrial appendage 50 may narrow quickly along the depth of the main body 60 or the left atrial appendage may maintain a generally constant lateral extent along a majority of depth of the main body 60 .
- the left atrial appendage 50 may include a distalmost region formed or arranged as a tail-like element associated with a distal portion of the main body 60 .
- the distalmost region may protrude radially or laterally away from the longitudinal axis 52 .
- FIGS. 3 and 3A generally illustrate an example prior art implant 100 , such as that disclosed in U.S. application Ser. No. 12/583,744, which is herein incorporated by reference.
- the implant 100 may generally comprise a support frame 110 partially covered by a membrane 120 , and a distal cap 130 .
- the support frame 110 may include proximal collar 111 and a plurality of struts forming a lattice of generally diamond-shaped wire portions extending therefrom.
- the support frame 110 may include a first row 112 of generally diamond-shaped wire portions, a second row 114 of generally diamond-shaped wire portions, and a third row 116 of elongated generally diamond-shaped wire portions.
- the support frame 110 may terminate at its distal end in a plurality of limbs 140 .
- the distal cap 130 may attach to the terminating distal ends of the limbs 140 .
- the support frame 110 may include a plurality of barbs 150 extending radially outward from the support frame 110 to penetrate tissue and inhibit longitudinal movement of the deployed implant 100 in a proximal direction.
- the barbs 150 may be generally arranged in a single row about the circumference of the support frame 110 and extending distally from a distal end of the second row 114 of diamond-shaped wire portions.
- the barbs 150 may each be disposed immediately alongside one strut forming one side portion of one elongated generally diamond-shaped wire portion of the third row 116 .
- the distal cap 130 includes a central hub 132 and a plurality of spokes 134 extending radially outward therefrom.
- the spokes 134 each have a first end 136 that attaches to a corresponding terminating distal end of one of the limbs 140 .
- the central hub 132 remains positioned proximal of the terminating distal ends of the limbs 140 at all operational positions of the implant 100 . Additionally, at no point during the operation of the implant 100 does any portion of the plurality of struts extend distally of the terminating distal ends of the limbs 140 . That is, the terminating distal ends of the limbs 140 are the distalmost element of the plurality of struts and/or the support frame 110 .
- the implant 100 may be disposed within a delivery catheter 190 to collectively form a medical device 195 .
- the medical device 195 may be percutaneously inserted into a patient to deliver the implant 100 to the left atrial appendage.
- the implant 100 may be disposed in a first, constrained position, such that the support frame 110 fits within the lumen of the delivery catheter 190 , as seen in FIG. 4A .
- the delivery catheter 190 may be withdrawn proximally to expose the implant 100 .
- the terminating distal ends of the limbs 140 and the first ends 136 of the spokes 134 are exposed and expand radially outward.
- the barbs 150 reach the distal end of the delivery catheter 190
- the terminating distal ends of the limbs 140 and the first ends 136 have extended radially outward to a second, flowering position.
- the distal cap 130 fully deploys radially outward, pulling the terminating distal ends of the limbs 140 radially outward to a third, mid-deployment position, as seen in FIG. 4C .
- the delivery catheter 190 is completely withdrawn from the implant 100 so that the implant 100 may assume a fourth, expanded position where the support frame 110 may extend radially outward from a central longitudinal axis farther than the terminating distal ends of the limbs 140 and/or the first ends 136 of the spokes 134 , as seen in FIG. 4D .
- the implant 100 in the fourth expanded position, pushes outward to “drive” into the tissue such that the tissue conforms to the shape of the outer surface of the implant 100 .
- the delivery catheter 190 and/or a delivery shaft (not shown) disposed therein may be disconnected from the proximal collar 111 and removed from the patient.
- recapture of the implant may be made easier by staggering the barbs into multiple rows such that less distally-directed force is required for the delivery catheter to remove any given row from the tissue of the left atrial appendage.
- changes in geometry to certain aspects of the implant may permit the use of more-compliant struts that also facilitate easier recapture and repositioning of the implant while maintaining at least the same amount of radially outward force at each of the barbs/anchors, and providing improved conformability to and sealing with the geometry of the left atrial appendage.
- changes in geometry at the distal end of the implant may facilitate use in shorter left atrial appendages, as well as easier and cheaper manufacturing of the implant, for example, avoiding manual assembly of the spokes to the limbs and/or individual laser welds to each of these joints. Accordingly, an example implant is disclosed herein, which may incorporate some or all of these changes.
- FIG. 5 illustrates a perspective view of a portion of an example implant 200 .
- the implant 200 may include a self-expanding monolithic support frame 210 extending from a proximal collar 212 to a distal collar 214 .
- the support frame 210 may include a plurality of struts forming a lattice of generally diamond-shaped wire portions.
- the support frame 210 may include, generally extending from proximally to distally, a first row 220 of generally diamond-shaped wire portions, a second row 222 of generally diamond-shaped wire portions adjacent the first row 220 , a third row 224 of generally diamond-shaped wire portions adjacent the second row 222 , a fourth row 226 of generally diamond-shaped wire portions adjacent the third row 224 , and a fifth row 228 of generally diamond-shaped wire portions adjacent the fourth row 226 .
- a plurality of legs may extend from the proximalmost and/or distalmost row(s) of generally diamond-shaped wire portions to the proximal and/or distal collar(s), respectively.
- the proximalmost and/or distalmost row(s) of generally diamond-shaped wire portions may be attached directly to the proximal and/or distal collar(s), respectively.
- additional or fewer rows of generally diamond-shaped wire portions may be included in the support frame 210 .
- Increasing the number of rows of generally diamond-shaped wire portions may permit a thinner strut thickness to be used, which may result in greater flexibility, compliance, and conformability of the plurality of struts and/or the support frame 210 .
- the support frame 210 when deployed, the support frame 210 may substantially conform to an internal geometry and/or shape of the lateral wall of the left atrial appendage, rather than forcing the lateral wall to conform to the shape of the support frame.
- the support frame 210 may include a plurality of anchors 250 provided to secure the implant 200 to the lateral wall of the left atrial appendage after deployment and thereby inhibit proximal movement of the implant 200 relative to the left atrial appendage.
- the plurality of anchors 250 may be arranged into a first row 252 of anchors and a second row 254 of anchors disposed proximally of the first row 252 of anchors, wherein the first row 252 of anchors and the second row 254 of anchors cooperate to form a staggered pattern about the circumference of the support frame 210 .
- Each of the plurality of anchors 250 may extend distally from a strut node junction 256 , such that a hook portion of each of the plurality of anchors 250 is positioned within an interior of one generally diamond-shaped wire portion, spaced apart from the adjacent struts. While not explicitly shown, additional rows or other alternate arrangements of the plurality of anchors 250 are also possible. In some embodiments, the plurality of anchors 250 may be equally spaced apart from each other. In some embodiments, the plurality of anchors 250 may be spaced an unequal intervals or distances from each other. In some embodiments, the staggered pattern may be uniform, such that angles and distances between adjacent anchors are the same.
- the staggered pattern may be non-uniform, such that some or all angles and distances between adjacent anchors are different.
- the staggered pattern may provide improved fixation strength, improved apposition to adjacent tissue, a reduced profile in a first, constrained position, reduced force required to remove the plurality of anchors 250 from the tissue (compared to placing all of the anchors in a single row) since only a portion of the total anchors is removed at a time, and reduced force required to retrieve the implant 200 back into a delivery catheter for repositioning (compared to having all of the anchors in a single row). Transition of the implant 200 from the first, constrained position to a second, flowering position to a third, mid-deployment position to a fourth, unconstrained position will be described in more detail below.
- FIG. 6 illustrates a cross-sectional view of a profile of the implant 200 and/or the support frame 210 in a fourth, unconstrained position.
- the profile In the cross-sectional view, certain features of the profile can be described.
- the profile In the fourth, unconstrained position, the profile extends distally from the proximal collar 212 and curves radially outward at a first bend 240 adjacent the proximal collar 212 .
- the first bend 240 forms a serpentine-like S-shape as the profile extends radially outward to a second bend 242 .
- the profile turns distally and radially inward, such that a first segment 270 of the profile forms a first angle 260 with a reference plane tangent to the second bend 242 and parallel to a central longitudinal axis of the implant 200 .
- the first angle 260 may be in a range from about 5 degrees to about 25 degrees, or about 10 degrees to about 20 degrees.
- the second bend 242 may include a short generally straight segment (about 0.025 inches to about 0.150 inches long) extending distally along the reference plane and an intermediate bend turning radially inward, such that the first segment 270 extends distally and radially inward from the intermediate bend.
- the first segment 270 extends distally and radially inward from the second bend 242 (and/or the intermediate bend) to a third bend 244 , where the profile turns radially inward at a sharper angle while still extending distally, such that a second segment 272 of the profile forms a second angle 262 with the first segment 270 of the profile (and/or a reference plane tangent thereto).
- the second angle 262 may be in a range from about 20 degrees to about 65 degrees, about 30 degrees to about 60 degrees, or about 40 degrees to about 50 degrees.
- the second segment 272 extends distally and radially inward from the third bend 244 to a fourth bend 246 adjacent the distal collar 214 .
- the profile turns proximally and continues radially inward to the distal collar 214 , such that a third segment 274 of the profile (and/or a reference plane tangent thereto) forms a third angle 264 with the central longitudinal axis.
- the third angle 264 may be in a range from about 35 degrees to about 75 degrees, about 40 degrees to about 65 degrees, or about 45 degrees to about 60 degrees.
- the third segment 274 extends proximally and radially inward from the fourth bend 246 to the distal collar 214 .
- the first segment 270 may have a first length
- the second segment 272 may have a second length
- the third segment 274 may have a third length.
- the length of the second segment 272 and the length of the third segment 274 may be compared as a ratio.
- the ratio of the length of the second segment 272 to the length of the third segment 274 (i.e., second length divided by third length) may be about 0.850 to about 2.160, about 1.000 to about 1.600, or about 1.100 to about 1.300.
- the distal ends of the plurality of struts of the support frame 210 (at the distal collar 214 ) may be disposed proximal of a distalmost portion of the plurality of struts of the support frame 210 and/or the implant 200 .
- an overall length of the implant 200 from a proximalmost portion to a distalmost portion, as measured along a line parallel to the central longitudinal axis may be from about 0.800 inches to about 0.900 inches, or about 0.830 inches, in the fourth, unconstrained position.
- a center of a radius forming the third bend 244 may be located, as measured along a line parallel to the central longitudinal axis, about 0.050 inches to about 0.360 inches, or about 0.130 inches to about 0.240 inches, or about 0.160 to about 0.180 inches proximal of the distalmost portion, in the fourth, unconstrained position. Additional constructional details may be found with the discussion directed to FIGS. 10 and 10A below.
- the implant 200 is illustrated in different stages of deployment.
- the implant 200 may be disposed within a lumen of a delivery catheter 290 to collectively form a medical device 295 .
- the medical device 295 may be percutaneously inserted into a patient to deliver the implant 200 to the left atrial appendage.
- the implant 200 may be disposed in a first, constrained position, with the first bend 240 , the second bend 242 , and the third bend 244 substantially straightened into an elongated shape such that the support frame 210 fits within the lumen of the delivery catheter 290 with the second segment 272 and the third segment 274 generally parallel to each other, as seen in FIG.
- a delivery shaft (not shown) disposed within the lumen of the delivery catheter 290 may be removably connected to the implant 200 at the proximal collar 212 .
- the delivery catheter 290 may be withdrawn proximally while the delivery shaft is held stationary, or the delivery shaft may be advanced distally while the delivery catheter 290 is held stationary (i.e., relative movement between the delivery catheter and the delivery shaft may be used), to expose the implant 200 within the left atrial appendage.
- the fourth bend 246 extends from a distal end of the delivery catheter 290 first with the distal collar 214 disposed proximal of the fourth bend 246 .
- the support frame 210 is exposed and expands radially outward slightly at the fourth bend 246 .
- the fourth bend 246 is opened compared to the first, constrained position, and the second segment 272 and the third bend 244 are translated radially outward compared to the first, constrained position, such that the second segment 272 angles distally and radially inward from the third bend 244 toward the fourth bend 246 to define a second, flowering position, wherein the exposed support frame 210 generally resembles a tulip.
- the implant 200 is partially disposed within the lumen of the delivery catheter 290 , with a portion of the first segment 270 and the second bend 242 remaining positioned within the lumen of the delivery catheter 290 .
- the first row 252 of anchors 250 may be disposed outside of the lumen of the delivery catheter 290 and the second row 254 of anchors 250 may be disposed inside of the lumen of the delivery catheter 290 .
- the plurality of anchors 250 may be prevented from engaging surrounding tissue (i.e., the lateral wall) of the left atrial appendage. At this stage of deployment, positioning of the implant 200 within the left atrial appendage may be adjusted without having to remove anchors from tissue.
- a proximal end of the second segment 272 and the third bend 244 is translated radially outward and distally relative to the fourth bend 246 (and/or compared to the second, flowering position) to a third, mid-deployment position.
- the third bend 244 constitutes a portion of the support frame 210 that defines a lateralmost extent from the central longitudinal axis, as seen in FIG. 9 .
- the fourth bend 246 widens or opens laterally as the third bend 244 translates distally.
- the first segment 270 extends distally and radially outward from the second bend 242 toward the third bend 244 .
- the second segment 272 extends less distally (i.e. extends a shorter longitudinal distance) and more radially inward (i.e., extends along a greater lateral or radial distance from the central longitudinal axis) from the second bend 242 toward the third bend 244 than in the second, flowering position.
- the first row 252 of anchors 250 may be disposed outside of the lumen of the delivery catheter 290 and the second row 254 of anchors 250 may be disposed outside of the lumen of the delivery catheter 290 .
- the first row 252 of anchors 250 may engage tissue (i.e., the lateral wall) of the left atrial appendage sufficiently to be effective, and the second row 254 of anchors 250 may or may not engage tissue of the left atrial appendage.
- positioning of the implant 200 within the left atrial appendage may be adjusted by removing the first row 252 of anchors 250 from tissue prior to adjustment. For a given quantity of anchors, having more than one row of anchors requires less axially-directed force to remove each individual row of anchors from the tissue than having all of the anchors in a single row.
- the delivery catheter 290 is completely withdrawn from the implant 200 so that the implant 200 is disposed outside of the delivery catheter 290 and may assume a fourth, unconstrained position where the support frame 210 at the second bend 242 may extend laterally or radially outward from the central longitudinal axis farther than at the third bend 244 , as seen in FIGS. 5 and 6 , to define a widest lateral extent of the implant 200 .
- the implant 200 may assume the profile discussed above with respect to FIGS. 5 and 6 .
- the implant 200 in some embodiments, may assume a deployed position wherein the implant 200 substantially conforms to the geometry of the left atrial appendage, as illustrated in FIG. 12 .
- the delivery catheter 190 and/or a delivery shaft (not shown) slidably disposed therein may be disconnected from the proximal collar 111 and removed from the patient.
- FIG. 10 illustrates the support frame 210 in an unrolled 2-D flat-pattern view, as cut from a tubular member, such as a metallic hypotube, or other suitable starting substrate.
- the monolithic support frame 210 may be laser cut from a single tubular member.
- the proximal collar 212 may be integrally formed with the support frame 210 and/or the plurality of struts.
- a plurality of free distal ends 202 may be fixedly attached to the distal collar 214 .
- the distal collar 214 may be formed as an annular ring member having an outer diameter smaller than an outer diameter of the tubular member and/or the proximal collar 212 , for example, as seen in FIG. 7 .
- the plurality of free distal ends 202 may be inserted into an interior of the distal collar 214 and fixedly attached thereto, for example, by adhesive(s), welding or soldering, friction fit, or other mechanical means.
- the plurality of free distal ends 202 may be formed and inserted into a distal end of the distal collar 214 , such that the plurality of struts extends distally from the distal collar 214 .
- a portion of the plurality of free distal ends 202 may extend through and/or proximally of the distal collar 214 .
- the distal collar 214 may be disposed within an interior of the implant 200 .
- the smaller outer diameter of the distal collar 214 facilitates a reduced profile in the first, constrained position.
- FIG. 10A shows a detailed view of a portion of the support frame 210 illustrated in FIG. 10 .
- the plurality of anchors 250 may be integrally formed with the plurality of struts of the support frame 210 from a single tubular member, such that the plurality of anchors 250 is unitary with the support frame 210 .
- the plurality of anchors 250 may be manufactured separately and added at a later time, such as by adhesive(s), welding or soldering, or other known attachment means. Subsequent forming, bending, heat-treating, and/or other procedures may be performed on the support frame 210 in order to achieve a desired profile or shape, such as that shown in FIG. 6 .
- a method of manufacturing the implant 200 may include the steps of:
- FIG. 11 illustrates the example implant 200 having a membrane 230 disposed over at least a portion of the support frame 210 .
- the implant 200 shown in FIGS. 5-9 may include the membrane 230 .
- the membrane 230 was not shown in FIGS. 5-9 .
- at least some of the plurality of anchors 250 project through the membrane 230 .
- the membrane 230 may be attached to the support frame 210 at each anchor 250 , for example, by passing each anchor 250 through the membrane 230 , such as through a pore or aperture.
- the membrane 230 may be attached to the support frame 210 by other suitable attachment means, such as but not limited to, adhesive(s), sutures or thread(s), welding or soldering, or combinations thereof.
- the membrane 230 may be permeable or impermeable to blood and/or other fluids, such as water.
- the membrane 230 may include a polymeric membrane, a metallic or polymeric mesh, a porous filter-like material, or other suitable construction.
- the membrane 230 prevents thrombi (i.e. blood clots, etc.) from passing through the membrane 230 and out of the left atrial appendage into the blood stream.
- the membrane 230 promotes endothelization after implantation, thereby effectively removing the left atrial appendage from the patient's circulatory system.
- FIG. 12 illustrates a partial cross-sectional view of the implant 200 disposed within an example left atrial appendage, such as that shown in FIG. 2 , in a deployed position.
- the support frame 210 may be compliant and substantially conform to and/or be in sealing engagement with the shape and/or geometry of the lateral wall of the left atrial appendage in the deployed position.
- the implant 200 may expand to the fourth, unconstrained position in the deployed position.
- the implant 200 may expand to a size, extent, or shape less than or different from the fourth, unconstrained position in the deployed position, which may be partially constrained, as determined by the surrounding tissue and/or lateral wall of the left atrial appendage.
- Reducing the thickness of the plurality of struts compared to the device shown in FIG. 3 increases the flexibility and compliance of the support frame 210 and/or the implant 200 , thereby permitting the implant 200 to conform to the tissue around it, rather than forcing the tissue to conform to the implant.
- the plurality of struts of the support frame 210 and/or the plurality of anchors 250 may be formed of or include a metallic material, a metallic alloy, a ceramic material, a rigid or high performance polymer, a metallic-polymer composite, combinations thereof, and the like.
- suitable materials may include metallic materials and/or alloys such as stainless steel (e.g., 303, 304v, or 316L stainless steel), nickel-titanium alloy (e.g., nitinol, such as super elastic or linear elastic nitinol), nickel-chromium alloy, nickel-chromium-iron alloy, cobalt alloy, nickel, titanium, platinum, or alternatively, a polymer material, such as a high performance polymer, or other suitable materials, and the like.
- nitinol was coined by a group of researchers at the United States Naval Ordinance Laboratory (NOL) who were the first to observe the shape memory behavior of this material.
- NOL United States Naval Ordinance Laboratory
- the word nitinol is an acronym including the chemical symbol for nickel (Ni), the chemical symbol for titanium (Ti), and an acronym identifying the Naval Ordinance Laboratory (NOL).
- the plurality of struts of the support frame 210 and/or the plurality of anchors 250 may be mixed with, may be doped with, may be coated with, or may otherwise include a radiopaque material.
- Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique such as X-ray during a medical procedure. This relatively bright image aids the user of device in determining its location.
- Suitable radiopaque materials may include, but are not limited to, bismuth subcarbonate, iodine, gold, platinum, palladium, tantalum, tungsten or tungsten alloy, and the like.
- the membrane 230 may be formed of or include a polymeric material, a metallic or metallic alloy material, a metallic-polymer composite, combinations thereof, and the like.
- the membrane 230 is preferably formed of polyethylene terephthalate (PET) such as DACRON®, or expanded polytetrafluoroethylene (ePTFE).
- PET polyethylene terephthalate
- ePTFE expanded polytetrafluoroethylene
- suitable polymers may include polyurethane, a polyether-ester such as ARNITEL® available from DSM Engineering Plastics, a polyester such as HYTREL® available from DuPont, a linear low density polyethylene such as REXELL®, a polyamide such as DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem, an elastomeric polyamide, a block polyamide/ether, a polyether block amide such as PEBA available under the trade name PEBAX®, silicones, polyethylene, Marlex high-density polyethylene, polytetrafluoroethylene (PTFE), polyetheretherketone (PEEK), polyimide (PI), and polyetherimide (PEI), a liquid crystal polymer (LCP) alone or blended with other materials.
- a polyether-ester such as ARNITEL® available from DSM Engineering Plastics
- HYTREL® available from DuPont
- a linear low density polyethylene such as REXELL®
- the delivery catheter 290 and/or the implant 200 may be made from, may be mixed with, may be coated with, or may otherwise include a material that provides a smooth, slick outer surface.
- the delivery catheter 290 and/or the implant 200 may include or be coated with a lubricious coating, a hydrophilic coating, a hydrophobic coating, a drug-eluting material, an anti-thrombus coating, or other suitable coating depending on the intended use or application.
- devices and methods in accordance with the disclosure can be adapted and configured for use in other parts of the anatomy of a patient.
- devices and methods in accordance with the disclosure can be adapted for use in the digestive or gastrointestinal tract, such as in the mouth, throat, small and large intestine, colon, rectum, and the like.
- devices and methods can be adapted and configured for use within the respiratory tract, such as in the mouth, nose, throat, bronchial passages, nasal passages, lungs, and the like.
- the apparatus and/or medical devices described herein with respect to percutaneous deployment may be used in other types of surgical procedures as appropriate.
- the medical devices may be deployed in a non-percutaneous procedure, such as an open heart procedure.
- Devices and methods in accordance with the invention can also be adapted and configured for other uses within the anatomy.
Abstract
A left atrial appendage closure implant may include a support frame including a first bend extending from a proximal collar to a second bend, a first segment extending from the second bend to a third bend, a second segment extending from the third bend to a fourth bend, and a third segment extending from the fourth bend to a distal collar, wherein the support frame is actuatable from a first constrained position to a second flowering position to a third mid-deployment position to a fourth unconstrained position. An implant may include a self-expanding support frame having a circumference and a central longitudinal axis, a membrane disposed over at least a portion of the support frame, and a plurality of anchors arranged into a first row and a second row such that the first row and the second row form a staggered pattern about the circumference of the support frame.
Description
- This application claims priority to U.S. Provisional Ser. No. 61/726,337 filed Nov. 14, 2012.
- The disclosure relates generally to percutaneous medical devices and more particularly to percutaneous medical devices for implantation into the left atrial appendage (LAA) of a heart.
- Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, affecting over 5.5 million people worldwide. Atrial fibrillation is the irregular, chaotic beating of the upper chambers of the heart. Electrical impulses discharge so rapidly that the atrial muscle quivers, or fibrillates. Episodes of atrial fibrillation may last a few minutes or several days. The most serious consequence of atrial fibrillation is ischemic stroke. It has been estimated that up to 20% of all strokes are related to atrial fibrillation. Most atrial fibrillation patients, regardless of the severity of their symptoms or frequency of episodes, require treatment to reduce the risk of stroke. The left atrial appendage (LAA) is a small organ attached to the left atrium of the heart as a pouch-like extension. In patients suffering from atrial fibrillation, the left atrial appendage may not properly contract with the left atrium, causing stagnant blood to pool within its interior, which can lead to the undesirable formation of thrombi within the left atrial appendage. Thrombi forming in the left atrial appendage may break loose from this area and enter the blood stream. Thrombi that migrate through the blood vessels may eventually plug a smaller vessel downstream and thereby contribute to stroke or heart attack. Clinical studies have shown that the majority of blood clots in patients with atrial fibrillation are found in the left atrial appendage. As a treatment, medical devices have been developed which are positioned in the left atrial appendage and deployed to close off the ostium of the left atrial appendage. Over time, the exposed surface(s) spanning the ostium of the left atrial appendage becomes covered with tissue (a process called endothelization), effectively removing the left atrial appendage from the circulatory system and reducing or eliminating the amount of thrombi which may enter the blood stream from the left atrial appendage.
- A continuing need exists for improved medical devices and methods to control thrombus formation within the left atrial appendage of patients suffering from atrial fibrillation.
- A medical device for left atrial appendage closure may include a delivery catheter having a lumen extending therethrough; and a left atrial appendage closure implant including a proximal collar, a distal collar, and a monolithic support frame extending therebetween, the support frame including: a first bend extending from the proximal collar to a second bend, a first segment extending from the second bend to a third bend, a second segment extending from the third bend to a fourth bend, and a third segment extending from the fourth bend to the distal collar, wherein the support frame is actuatable from a first constrained position to a second flowering position to a third mid-deployment position to a fourth unconstrained position.
- A left atrial appendage closure implant may include a self-expanding support frame having a circumference and a central longitudinal axis, a membrane disposed over at least a portion of the support frame, and a plurality of anchors arranged into a first row and a second row such that the first row and the second row form a staggered pattern about the circumference of the support frame.
- A method of manufacturing a left atrial appendage closure implant may include the steps of:
-
- obtaining an elongate tubular member having a lumen extending therethrough and an annular ring member;
- laser cutting the tubular member to form a proximal collar, a plurality of struts, a plurality of anchors interspersed among the plurality of struts, and a plurality of free distal ends;
- forming the plurality of struts into a lattice of generally diamond-shaped wire portions;
- fixedly attaching the plurality of free distal ends to the annular ring member;
- positioning the plurality of struts such that a cross-sectional profile of the left atrial appendage closure implant in an unconstrained position includes a first bend extending radially outward from the proximal collar to a second bend, a first segment extending distally and radially inward from the second bend to a third bend, a second segment extending distally and radially inward from the third bend to a fourth bend, and a third segment extending proximally and radially inward from the fourth bend to the annular ring member; and
- attaching a membrane over at least a portion of the plurality of struts such that the plurality of anchors extends through the membrane.
-
FIG. 1 is a schematic partial cross-sectional view of a heart; -
FIG. 2 is a schematic partial cross-sectional view of an example left atrial appendage; -
FIGS. 3-3A illustrate an example prior art implant; -
FIG. 4A is a partial cross-sectional view of the example prior art implant ofFIGS. 3-3A in a first, constrained position; -
FIGS. 4B-4D illustrate perspective views of the example prior art implant ofFIGS. 3-3A in various stages of deployment; -
FIG. 5 illustrates a portion of an example medical device according to the present disclosure; -
FIG. 6 is a partial cross-sectional view of the example medical device ofFIG. 5 ; -
FIG. 7 is a partial cross-sectional view of the example medical device ofFIG. 5 in a first, constrained position; -
FIG. 8 illustrates the example medical device ofFIG. 5 partially deployed; -
FIG. 9 illustrates the example medical device ofFIG. 5 partially deployed; -
FIG. 10 illustrates the example medical device ofFIG. 5 during manufacture in a flat-pattern view; -
FIG. 10A is a detailed view of a portion of the example medical device shown inFIG. 10 ; -
FIG. 11 illustrates a portion of the example medical device ofFIG. 5 ; and -
FIG. 12 is a partial cross-sectional view of the example medical device ofFIGS. 5 and 11 deployed within the example left atrial appendage ofFIG. 2 . - While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in greater detail below. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.
- For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
- The terms “upstream” and “downstream” refer to a position or location relative to the direction of blood flow through a particular element or location, such as a vessel (i.e., the aorta), a heart valve (i.e., the aortic valve), and the like.
- The terms “proximal” and “distal” shall generally refer to the relative position, orientation, or direction of an element or action, from the perspective of a clinician using the medical device, relative to one another. While the terms are not meant to be limiting, “proximal” may generally be considered closer to the clinician or an exterior of a patient, and “distal” may generally be considered to be farther away from the clinician, along the length of the medical device.
- The terms “monolithic” and “unitary” shall generally refer to an element or elements made from or consisting of a single structure or base unit/element. A monolithic and/or unitary element shall exclude structure and/or features made by assembling or otherwise joining multiple discrete elements together.
- All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about”, in the context of numeric values, generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the term “about” may include numbers that are rounded to the nearest significant figure. Other uses of the term “about” (i.e., in a context other than numeric values) may be assumed to have their ordinary and customary definition(s), as understood from and consistent with the context of the specification, unless otherwise specified.
- Weight percent, percent by weight, wt %, wt-%, % by weight, and the like are synonyms that refer to the concentration of a substance as the weight of that substance divided by the weight of the composition and multiplied by 100.
- The recitation of numerical ranges by endpoints includes all numbers within that range, including the endpoints (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
- As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
- The following description should be read with reference to the drawings wherein like reference numerals indicate like elements throughout the several views. The detailed description and drawings are intended to illustrate but not limit the claimed invention. Those skilled in the art will recognize that the various elements described and/or shown may be arranged in various combinations and configurations without departing from the scope of the disclosure. The various individual elements described below, even if not explicitly shown in a particular combination, are nevertheless contemplated as being combinable or arrangable with each other to form other additional embodiments or to complement and/or enrich the described embodiment(s), as would be understood by one of ordinary skill in the art.
- The occurrence of thrombi in the left atrial appendage (LAA) during atrial fibrillation may be due to stagnancy of the blood pool in the LAA. The blood may still be pulled out of the left atrium by the left ventricle, however less effectively due to the irregular contraction of the left atrium caused by atrial fibrillation. Therefore, instead of an active support of the blood flow by a contracting left atrium and left atrial appendage, filling of the left ventricle may depend primarily or solely on the suction effect created by the left ventricle. Further, the contraction of the left atrial appendage may not be in sync with the cycle of the left ventricle. For example, contraction of the left atrial appendage may be out of phase up to 180 degrees with the left ventricle, which may create significant resistance to the desired flow of blood. Further still, most left atrial appendage geometries are complex and highly variable, with large irregular surface areas and a narrow ostium or opening compared to the depth of the left atrial appendage. These aspects as well as others, taken individually or in various combinations, may lead to high flow resistance of blood out of the left atrial appendage.
- In an effort to reduce the occurrence of thrombi formation within the left atrial appendage and prevent thrombi from entering the blood stream from within the left atrial appendage, a medical device has been developed that closes off the left atrial appendage from the heart and/or circulatory system, thereby lowering the risk of stroke due to thrombolytic material entering the blood stream from the left atrial appendage.
- Turning to the drawings,
FIG. 1 is a partial cross-sectional view of certain elements of ahuman heart 10 and some immediately adjacent blood vessels. Aheart 10 may include aleft ventricle 12, aright ventricle 14, aleft atrium 16, and aright atrium 18. Anaortic valve 22 is disposed between theleft ventricle 12 and anaorta 20. A pulmonary orsemi-lunar valve 26 is disposed between theright ventricle 14 and apulmonary artery 24. Asuperior vena cava 28 and aninferior vena cava 30 return blood from the body to theright atrium 18. Amitral valve 32 is disposed between theleft atrium 16 and theleft ventricle 12. Atricuspid valve 34 is disposed between theright atrium 18 and theright ventricle 14.Pulmonary veins 36 return blood from the lungs to theleft atrium 16. A left atrial appendage (LAA) 50 is attached to and in fluid communication with theleft atrium 16. -
FIG. 2 is a partial cross-sectional view of an example leftatrial appendage 50. As discussed above, the leftatrial appendage 50 may have a complex geometry and/or irregular surface area. Those skilled in the art will recognize that the illustrated LAA is merely one of many possible shapes and sizes for the LAA, which may vary from patient to patient. Those of skill in the art will also recognize that the medical devices and methods disclosed herein may be adapted for various sizes and shapes of the LAA, as necessary. A leftatrial appendage 50 may include a generallylongitudinal axis 52 arranged along a depth of amain body 60 of the leftatrial appendage 50. Themain body 60 may include alateral wall 54 and anostium 56 forming aproximal mouth 58. In some embodiments, a lateral extent of theostium 56 and/or thelateral wall 54 may be smaller or less than a depth of themain body 60 along thelongitudinal axis 52, or a depth of themain body 60 may be greater than a lateral extent of theostium 56 and/or thelateral wall 54. In some embodiments, the leftatrial appendage 50 may narrow quickly along the depth of themain body 60 or the left atrial appendage may maintain a generally constant lateral extent along a majority of depth of themain body 60. In some embodiments, the leftatrial appendage 50 may include a distalmost region formed or arranged as a tail-like element associated with a distal portion of themain body 60. In some embodiments, the distalmost region may protrude radially or laterally away from thelongitudinal axis 52. -
FIGS. 3 and 3A generally illustrate an exampleprior art implant 100, such as that disclosed in U.S. application Ser. No. 12/583,744, which is herein incorporated by reference. Theimplant 100 may generally comprise asupport frame 110 partially covered by amembrane 120, and adistal cap 130. Thesupport frame 110 may includeproximal collar 111 and a plurality of struts forming a lattice of generally diamond-shaped wire portions extending therefrom. Thesupport frame 110 may include afirst row 112 of generally diamond-shaped wire portions, asecond row 114 of generally diamond-shaped wire portions, and athird row 116 of elongated generally diamond-shaped wire portions. Thesupport frame 110 may terminate at its distal end in a plurality oflimbs 140. Thedistal cap 130 may attach to the terminating distal ends of thelimbs 140. Thesupport frame 110 may include a plurality ofbarbs 150 extending radially outward from thesupport frame 110 to penetrate tissue and inhibit longitudinal movement of the deployedimplant 100 in a proximal direction. Thebarbs 150 may be generally arranged in a single row about the circumference of thesupport frame 110 and extending distally from a distal end of thesecond row 114 of diamond-shaped wire portions. Thebarbs 150 may each be disposed immediately alongside one strut forming one side portion of one elongated generally diamond-shaped wire portion of thethird row 116. - The
distal cap 130 includes acentral hub 132 and a plurality ofspokes 134 extending radially outward therefrom. Thespokes 134 each have afirst end 136 that attaches to a corresponding terminating distal end of one of thelimbs 140. Thecentral hub 132 remains positioned proximal of the terminating distal ends of thelimbs 140 at all operational positions of theimplant 100. Additionally, at no point during the operation of theimplant 100 does any portion of the plurality of struts extend distally of the terminating distal ends of thelimbs 140. That is, the terminating distal ends of thelimbs 140 are the distalmost element of the plurality of struts and/or thesupport frame 110. - Turning to
FIGS. 4A-4D , during delivery of the exampleprior art implant 100 into a left atrial appendage, theimplant 100 may be disposed within adelivery catheter 190 to collectively form amedical device 195. Themedical device 195 may be percutaneously inserted into a patient to deliver theimplant 100 to the left atrial appendage. Initially, theimplant 100 may be disposed in a first, constrained position, such that thesupport frame 110 fits within the lumen of thedelivery catheter 190, as seen inFIG. 4A . Upon reaching the left atrial appendage, thedelivery catheter 190 may be withdrawn proximally to expose theimplant 100. As thedelivery catheter 190 is withdrawn, the terminating distal ends of thelimbs 140 and the first ends 136 of thespokes 134 are exposed and expand radially outward. As seen inFIG. 4B , when thebarbs 150 reach the distal end of thedelivery catheter 190, the terminating distal ends of thelimbs 140 and the first ends 136 have extended radially outward to a second, flowering position. Continuing to withdrawn thedelivery catheter 190, thedistal cap 130 fully deploys radially outward, pulling the terminating distal ends of thelimbs 140 radially outward to a third, mid-deployment position, as seen inFIG. 4C . Next, thedelivery catheter 190 is completely withdrawn from theimplant 100 so that theimplant 100 may assume a fourth, expanded position where thesupport frame 110 may extend radially outward from a central longitudinal axis farther than the terminating distal ends of thelimbs 140 and/or the first ends 136 of thespokes 134, as seen inFIG. 4D . Theimplant 100, in the fourth expanded position, pushes outward to “drive” into the tissue such that the tissue conforms to the shape of the outer surface of theimplant 100. Lastly, thedelivery catheter 190 and/or a delivery shaft (not shown) disposed therein may be disconnected from theproximal collar 111 and removed from the patient. - Applicants have found that recapture of the implant may be made easier by staggering the barbs into multiple rows such that less distally-directed force is required for the delivery catheter to remove any given row from the tissue of the left atrial appendage. Additionally, changes in geometry to certain aspects of the implant may permit the use of more-compliant struts that also facilitate easier recapture and repositioning of the implant while maintaining at least the same amount of radially outward force at each of the barbs/anchors, and providing improved conformability to and sealing with the geometry of the left atrial appendage. Further still, changes in geometry at the distal end of the implant may facilitate use in shorter left atrial appendages, as well as easier and cheaper manufacturing of the implant, for example, avoiding manual assembly of the spokes to the limbs and/or individual laser welds to each of these joints. Accordingly, an example implant is disclosed herein, which may incorporate some or all of these changes.
-
FIG. 5 illustrates a perspective view of a portion of anexample implant 200. Theimplant 200 may include a self-expandingmonolithic support frame 210 extending from aproximal collar 212 to adistal collar 214. In some embodiments, thesupport frame 210 may include a plurality of struts forming a lattice of generally diamond-shaped wire portions. In some embodiments, thesupport frame 210 may include, generally extending from proximally to distally, afirst row 220 of generally diamond-shaped wire portions, asecond row 222 of generally diamond-shaped wire portions adjacent thefirst row 220, athird row 224 of generally diamond-shaped wire portions adjacent thesecond row 222, afourth row 226 of generally diamond-shaped wire portions adjacent thethird row 224, and afifth row 228 of generally diamond-shaped wire portions adjacent thefourth row 226. In some embodiments, a plurality of legs may extend from the proximalmost and/or distalmost row(s) of generally diamond-shaped wire portions to the proximal and/or distal collar(s), respectively. In some embodiments, the proximalmost and/or distalmost row(s) of generally diamond-shaped wire portions may be attached directly to the proximal and/or distal collar(s), respectively. As will be appreciated by the skilled artisan, additional or fewer rows of generally diamond-shaped wire portions may be included in thesupport frame 210. Increasing the number of rows of generally diamond-shaped wire portions may permit a thinner strut thickness to be used, which may result in greater flexibility, compliance, and conformability of the plurality of struts and/or thesupport frame 210. In other words, when deployed, thesupport frame 210 may substantially conform to an internal geometry and/or shape of the lateral wall of the left atrial appendage, rather than forcing the lateral wall to conform to the shape of the support frame. - In some embodiments, the
support frame 210 may include a plurality ofanchors 250 provided to secure theimplant 200 to the lateral wall of the left atrial appendage after deployment and thereby inhibit proximal movement of theimplant 200 relative to the left atrial appendage. In some embodiments, the plurality ofanchors 250 may be arranged into afirst row 252 of anchors and asecond row 254 of anchors disposed proximally of thefirst row 252 of anchors, wherein thefirst row 252 of anchors and thesecond row 254 of anchors cooperate to form a staggered pattern about the circumference of thesupport frame 210. Each of the plurality ofanchors 250 may extend distally from astrut node junction 256, such that a hook portion of each of the plurality ofanchors 250 is positioned within an interior of one generally diamond-shaped wire portion, spaced apart from the adjacent struts. While not explicitly shown, additional rows or other alternate arrangements of the plurality ofanchors 250 are also possible. In some embodiments, the plurality ofanchors 250 may be equally spaced apart from each other. In some embodiments, the plurality ofanchors 250 may be spaced an unequal intervals or distances from each other. In some embodiments, the staggered pattern may be uniform, such that angles and distances between adjacent anchors are the same. In some embodiments, the staggered pattern may be non-uniform, such that some or all angles and distances between adjacent anchors are different. The staggered pattern may provide improved fixation strength, improved apposition to adjacent tissue, a reduced profile in a first, constrained position, reduced force required to remove the plurality ofanchors 250 from the tissue (compared to placing all of the anchors in a single row) since only a portion of the total anchors is removed at a time, and reduced force required to retrieve theimplant 200 back into a delivery catheter for repositioning (compared to having all of the anchors in a single row). Transition of theimplant 200 from the first, constrained position to a second, flowering position to a third, mid-deployment position to a fourth, unconstrained position will be described in more detail below. -
FIG. 6 illustrates a cross-sectional view of a profile of theimplant 200 and/or thesupport frame 210 in a fourth, unconstrained position. In the cross-sectional view, certain features of the profile can be described. In the fourth, unconstrained position, the profile extends distally from theproximal collar 212 and curves radially outward at afirst bend 240 adjacent theproximal collar 212. Thefirst bend 240 forms a serpentine-like S-shape as the profile extends radially outward to asecond bend 242. At thesecond bend 242, the profile turns distally and radially inward, such that afirst segment 270 of the profile forms afirst angle 260 with a reference plane tangent to thesecond bend 242 and parallel to a central longitudinal axis of theimplant 200. In some embodiments, thefirst angle 260 may be in a range from about 5 degrees to about 25 degrees, or about 10 degrees to about 20 degrees. In some embodiments, thesecond bend 242 may include a short generally straight segment (about 0.025 inches to about 0.150 inches long) extending distally along the reference plane and an intermediate bend turning radially inward, such that thefirst segment 270 extends distally and radially inward from the intermediate bend. Thefirst segment 270 extends distally and radially inward from the second bend 242 (and/or the intermediate bend) to athird bend 244, where the profile turns radially inward at a sharper angle while still extending distally, such that asecond segment 272 of the profile forms asecond angle 262 with thefirst segment 270 of the profile (and/or a reference plane tangent thereto). In some embodiments, thesecond angle 262 may be in a range from about 20 degrees to about 65 degrees, about 30 degrees to about 60 degrees, or about 40 degrees to about 50 degrees. Thesecond segment 272 extends distally and radially inward from thethird bend 244 to afourth bend 246 adjacent thedistal collar 214. At thefourth bend 246, the profile turns proximally and continues radially inward to thedistal collar 214, such that athird segment 274 of the profile (and/or a reference plane tangent thereto) forms athird angle 264 with the central longitudinal axis. In some embodiments, thethird angle 264 may be in a range from about 35 degrees to about 75 degrees, about 40 degrees to about 65 degrees, or about 45 degrees to about 60 degrees. Thethird segment 274 extends proximally and radially inward from thefourth bend 246 to thedistal collar 214. Thefirst segment 270 may have a first length, thesecond segment 272 may have a second length, and thethird segment 274 may have a third length. The length of thesecond segment 272 and the length of thethird segment 274 may be compared as a ratio. In some embodiments, the ratio of the length of thesecond segment 272 to the length of the third segment 274 (i.e., second length divided by third length) may be about 0.850 to about 2.160, about 1.000 to about 1.600, or about 1.100 to about 1.300. As may be seen from the profile illustrated inFIG. 6 , the distal ends of the plurality of struts of the support frame 210 (at the distal collar 214) may be disposed proximal of a distalmost portion of the plurality of struts of thesupport frame 210 and/or theimplant 200. In some embodiments, an overall length of theimplant 200 from a proximalmost portion to a distalmost portion, as measured along a line parallel to the central longitudinal axis, may be from about 0.800 inches to about 0.900 inches, or about 0.830 inches, in the fourth, unconstrained position. In some embodiments, a center of a radius forming thethird bend 244 may be located, as measured along a line parallel to the central longitudinal axis, about 0.050 inches to about 0.360 inches, or about 0.130 inches to about 0.240 inches, or about 0.160 to about 0.180 inches proximal of the distalmost portion, in the fourth, unconstrained position. Additional constructional details may be found with the discussion directed toFIGS. 10 and 10A below. - Turning to
FIGS. 7-9 , theimplant 200 is illustrated in different stages of deployment. During delivery of theimplant 200 to a left atrial appendage, theimplant 200 may be disposed within a lumen of adelivery catheter 290 to collectively form amedical device 295. Themedical device 295 may be percutaneously inserted into a patient to deliver theimplant 200 to the left atrial appendage. Initially, theimplant 200 may be disposed in a first, constrained position, with thefirst bend 240, thesecond bend 242, and thethird bend 244 substantially straightened into an elongated shape such that thesupport frame 210 fits within the lumen of thedelivery catheter 290 with thesecond segment 272 and thethird segment 274 generally parallel to each other, as seen inFIG. 7 . A delivery shaft (not shown) disposed within the lumen of thedelivery catheter 290 may be removably connected to theimplant 200 at theproximal collar 212. Upon reaching the left atrial appendage, thedelivery catheter 290 may be withdrawn proximally while the delivery shaft is held stationary, or the delivery shaft may be advanced distally while thedelivery catheter 290 is held stationary (i.e., relative movement between the delivery catheter and the delivery shaft may be used), to expose theimplant 200 within the left atrial appendage. As thedelivery catheter 290 is withdrawn, thefourth bend 246 extends from a distal end of thedelivery catheter 290 first with thedistal collar 214 disposed proximal of thefourth bend 246. - As the
delivery catheter 290 is withdrawn, thesupport frame 210 is exposed and expands radially outward slightly at thefourth bend 246. Next, as seen inFIG. 8 , as thethird bend 244 exits thedelivery catheter 290, or about when the plurality ofanchors 250 initially begins to exit the distal end of thedelivery catheter 290, thefourth bend 246 is opened compared to the first, constrained position, and thesecond segment 272 and thethird bend 244 are translated radially outward compared to the first, constrained position, such that thesecond segment 272 angles distally and radially inward from thethird bend 244 toward thefourth bend 246 to define a second, flowering position, wherein the exposedsupport frame 210 generally resembles a tulip. In the second, flowering position, theimplant 200 is partially disposed within the lumen of thedelivery catheter 290, with a portion of thefirst segment 270 and thesecond bend 242 remaining positioned within the lumen of thedelivery catheter 290. In the second, flowering position, thefirst row 252 ofanchors 250 may be disposed outside of the lumen of thedelivery catheter 290 and thesecond row 254 ofanchors 250 may be disposed inside of the lumen of thedelivery catheter 290. In the second, flowering position, the plurality ofanchors 250 may be prevented from engaging surrounding tissue (i.e., the lateral wall) of the left atrial appendage. At this stage of deployment, positioning of theimplant 200 within the left atrial appendage may be adjusted without having to remove anchors from tissue. - Continuing to withdraw the
delivery catheter 290, a proximal end of thesecond segment 272 and thethird bend 244 is translated radially outward and distally relative to the fourth bend 246 (and/or compared to the second, flowering position) to a third, mid-deployment position. In the third, mid-deployment position, thethird bend 244 constitutes a portion of thesupport frame 210 that defines a lateralmost extent from the central longitudinal axis, as seen inFIG. 9 . Similarly, thefourth bend 246 widens or opens laterally as thethird bend 244 translates distally. In the third, mid-deployment position, thefirst segment 270 extends distally and radially outward from thesecond bend 242 toward thethird bend 244. In the third, mid-deployment position, thesecond segment 272 extends less distally (i.e. extends a shorter longitudinal distance) and more radially inward (i.e., extends along a greater lateral or radial distance from the central longitudinal axis) from thesecond bend 242 toward thethird bend 244 than in the second, flowering position. In the third, mid-deployment position, thefirst row 252 ofanchors 250 may be disposed outside of the lumen of thedelivery catheter 290 and thesecond row 254 ofanchors 250 may be disposed outside of the lumen of thedelivery catheter 290. In the third, mid-deployment position, thefirst row 252 ofanchors 250 may engage tissue (i.e., the lateral wall) of the left atrial appendage sufficiently to be effective, and thesecond row 254 ofanchors 250 may or may not engage tissue of the left atrial appendage. At this stage of deployment, positioning of theimplant 200 within the left atrial appendage may be adjusted by removing thefirst row 252 ofanchors 250 from tissue prior to adjustment. For a given quantity of anchors, having more than one row of anchors requires less axially-directed force to remove each individual row of anchors from the tissue than having all of the anchors in a single row. - Next, the
delivery catheter 290 is completely withdrawn from theimplant 200 so that theimplant 200 is disposed outside of thedelivery catheter 290 and may assume a fourth, unconstrained position where thesupport frame 210 at thesecond bend 242 may extend laterally or radially outward from the central longitudinal axis farther than at thethird bend 244, as seen inFIGS. 5 and 6 , to define a widest lateral extent of theimplant 200. In the fourth, unconstrained position, theimplant 200 may assume the profile discussed above with respect toFIGS. 5 and 6 . During use and implantation, theimplant 200, in some embodiments, may assume a deployed position wherein theimplant 200 substantially conforms to the geometry of the left atrial appendage, as illustrated inFIG. 12 . Lastly, thedelivery catheter 190 and/or a delivery shaft (not shown) slidably disposed therein may be disconnected from theproximal collar 111 and removed from the patient. -
FIG. 10 illustrates thesupport frame 210 in an unrolled 2-D flat-pattern view, as cut from a tubular member, such as a metallic hypotube, or other suitable starting substrate. In some embodiments, themonolithic support frame 210 may be laser cut from a single tubular member. The skilled artisan will recognize that other manufacturing methods known in the art may be used including, but not limited to, machining, chemical etching, water cutting, EDM, etc. In some embodiments, theproximal collar 212 may be integrally formed with thesupport frame 210 and/or the plurality of struts. In some embodiments, after cutting thesupport frame 210, a plurality of free distal ends 202 may be fixedly attached to thedistal collar 214. In some embodiments, thedistal collar 214 may be formed as an annular ring member having an outer diameter smaller than an outer diameter of the tubular member and/or theproximal collar 212, for example, as seen inFIG. 7 . The plurality of free distal ends 202 may be inserted into an interior of thedistal collar 214 and fixedly attached thereto, for example, by adhesive(s), welding or soldering, friction fit, or other mechanical means. In some embodiments, the plurality of free distal ends 202 may be formed and inserted into a distal end of thedistal collar 214, such that the plurality of struts extends distally from thedistal collar 214. In some embodiments, a portion of the plurality of free distal ends 202 may extend through and/or proximally of thedistal collar 214. In other words, thedistal collar 214 may be disposed within an interior of theimplant 200. The smaller outer diameter of thedistal collar 214 facilitates a reduced profile in the first, constrained position. -
FIG. 10A shows a detailed view of a portion of thesupport frame 210 illustrated inFIG. 10 . In the portion shown, one can see how thefirst row 252 and thesecond row 254 ofanchors 250 may be formed. In some embodiments, such as shown inFIG. 10A , the plurality ofanchors 250 may be integrally formed with the plurality of struts of thesupport frame 210 from a single tubular member, such that the plurality ofanchors 250 is unitary with thesupport frame 210. In some embodiments, the plurality ofanchors 250 may be manufactured separately and added at a later time, such as by adhesive(s), welding or soldering, or other known attachment means. Subsequent forming, bending, heat-treating, and/or other procedures may be performed on thesupport frame 210 in order to achieve a desired profile or shape, such as that shown inFIG. 6 . - In some embodiments, a method of manufacturing the
implant 200 may include the steps of: -
- obtaining an elongate tubular member having a lumen extending therethrough and an annular ring member;
- laser cutting the tubular member to form a proximal collar, a plurality of struts, a plurality of anchors interspersed among the plurality of struts, and a plurality of free distal ends, as a single monolithic structure;
- forming the plurality of struts into a lattice of generally diamond-shaped wire portions;
- fixedly attaching the plurality of free distal ends to the annular ring member;
- positioning the plurality of struts such that a cross-sectional profile of the left atrial appendage closure implant in an unconstrained position includes a first bend extending radially outward from the proximal collar to a second bend, a first segment extending distally and radially inward from the second bend to a third bend, a second segment extending distally and radially inward from the third bend to a fourth bend, and a third segment extending proximally and radially inward from the fourth bend to the annular ring member; and
- attaching a membrane over at least a portion of the plurality of struts such that the plurality of anchors extends through the membrane.
-
FIG. 11 illustrates theexample implant 200 having amembrane 230 disposed over at least a portion of thesupport frame 210. While not explicitly illustrated, theimplant 200 shown inFIGS. 5-9 may include themembrane 230. In the interest of clarity, themembrane 230 was not shown inFIGS. 5-9 . In some embodiments, at least some of the plurality ofanchors 250 project through themembrane 230. In some embodiments, themembrane 230 may be attached to thesupport frame 210 at eachanchor 250, for example, by passing eachanchor 250 through themembrane 230, such as through a pore or aperture. In some embodiments, themembrane 230 may be attached to thesupport frame 210 by other suitable attachment means, such as but not limited to, adhesive(s), sutures or thread(s), welding or soldering, or combinations thereof. In some embodiments, themembrane 230 may be permeable or impermeable to blood and/or other fluids, such as water. In some embodiments, themembrane 230 may include a polymeric membrane, a metallic or polymeric mesh, a porous filter-like material, or other suitable construction. In some embodiments, themembrane 230 prevents thrombi (i.e. blood clots, etc.) from passing through themembrane 230 and out of the left atrial appendage into the blood stream. In some embodiments, themembrane 230 promotes endothelization after implantation, thereby effectively removing the left atrial appendage from the patient's circulatory system. -
FIG. 12 illustrates a partial cross-sectional view of theimplant 200 disposed within an example left atrial appendage, such as that shown inFIG. 2 , in a deployed position. As can be seen inFIG. 12 , thesupport frame 210 may be compliant and substantially conform to and/or be in sealing engagement with the shape and/or geometry of the lateral wall of the left atrial appendage in the deployed position. At its largest size, extent, or shape, theimplant 200 may expand to the fourth, unconstrained position in the deployed position. In some embodiments, theimplant 200 may expand to a size, extent, or shape less than or different from the fourth, unconstrained position in the deployed position, which may be partially constrained, as determined by the surrounding tissue and/or lateral wall of the left atrial appendage. Reducing the thickness of the plurality of struts compared to the device shown inFIG. 3 increases the flexibility and compliance of thesupport frame 210 and/or theimplant 200, thereby permitting theimplant 200 to conform to the tissue around it, rather than forcing the tissue to conform to the implant. - In some embodiments, the plurality of struts of the
support frame 210 and/or the plurality ofanchors 250 may be formed of or include a metallic material, a metallic alloy, a ceramic material, a rigid or high performance polymer, a metallic-polymer composite, combinations thereof, and the like. Some examples of some suitable materials may include metallic materials and/or alloys such as stainless steel (e.g., 303, 304v, or 316L stainless steel), nickel-titanium alloy (e.g., nitinol, such as super elastic or linear elastic nitinol), nickel-chromium alloy, nickel-chromium-iron alloy, cobalt alloy, nickel, titanium, platinum, or alternatively, a polymer material, such as a high performance polymer, or other suitable materials, and the like. The word nitinol was coined by a group of researchers at the United States Naval Ordinance Laboratory (NOL) who were the first to observe the shape memory behavior of this material. The word nitinol is an acronym including the chemical symbol for nickel (Ni), the chemical symbol for titanium (Ti), and an acronym identifying the Naval Ordinance Laboratory (NOL). - In some embodiments, the plurality of struts of the
support frame 210 and/or the plurality ofanchors 250 may be mixed with, may be doped with, may be coated with, or may otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique such as X-ray during a medical procedure. This relatively bright image aids the user of device in determining its location. Suitable radiopaque materials may include, but are not limited to, bismuth subcarbonate, iodine, gold, platinum, palladium, tantalum, tungsten or tungsten alloy, and the like. - In some embodiments, the
membrane 230 may be formed of or include a polymeric material, a metallic or metallic alloy material, a metallic-polymer composite, combinations thereof, and the like. In some embodiments, themembrane 230 is preferably formed of polyethylene terephthalate (PET) such as DACRON®, or expanded polytetrafluoroethylene (ePTFE). Other examples of suitable polymers may include polyurethane, a polyether-ester such as ARNITEL® available from DSM Engineering Plastics, a polyester such as HYTREL® available from DuPont, a linear low density polyethylene such as REXELL®, a polyamide such as DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem, an elastomeric polyamide, a block polyamide/ether, a polyether block amide such as PEBA available under the trade name PEBAX®, silicones, polyethylene, Marlex high-density polyethylene, polytetrafluoroethylene (PTFE), polyetheretherketone (PEEK), polyimide (PI), and polyetherimide (PEI), a liquid crystal polymer (LCP) alone or blended with other materials. - In some embodiments, the
delivery catheter 290 and/or theimplant 200 may be made from, may be mixed with, may be coated with, or may otherwise include a material that provides a smooth, slick outer surface. In some embodiments, thedelivery catheter 290 and/or theimplant 200 may include or be coated with a lubricious coating, a hydrophilic coating, a hydrophobic coating, a drug-eluting material, an anti-thrombus coating, or other suitable coating depending on the intended use or application. - It should be understood that although the above discussion was focused on a medical device and methods of use within the vascular system of a patient, other embodiments of medical devices or methods in accordance with the disclosure can be adapted and configured for use in other parts of the anatomy of a patient. For example, devices and methods in accordance with the disclosure can be adapted for use in the digestive or gastrointestinal tract, such as in the mouth, throat, small and large intestine, colon, rectum, and the like. For another example, devices and methods can be adapted and configured for use within the respiratory tract, such as in the mouth, nose, throat, bronchial passages, nasal passages, lungs, and the like. Similarly, the apparatus and/or medical devices described herein with respect to percutaneous deployment may be used in other types of surgical procedures as appropriate. For example, in some embodiments, the medical devices may be deployed in a non-percutaneous procedure, such as an open heart procedure. Devices and methods in accordance with the invention can also be adapted and configured for other uses within the anatomy.
- It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
Claims (19)
1. A medical device for left atrial appendage closure, comprising:
a delivery catheter having a lumen extending therethrough; and
a left atrial appendage closure implant comprising:
a proximal collar, a distal collar, and a monolithic support frame extending therebetween, the support frame including:
a first bend extending from the proximal collar to a second bend;
a first segment extending from the second bend to a third bend;
a second segment extending from the third bend to a fourth bend; and
a third segment extending from the fourth bend to the distal collar;
wherein the support frame is actuatable from a first constrained position to a second flowering position to a third mid-deployment position to a fourth unconstrained position.
2. The medical device of claim 1 , wherein in the first constrained position, the left atrial appendage closure implant is disposed within the lumen of the delivery catheter with the first bend, the second bend, and the third bend substantially straightened into an elongated shape, and the fourth bend bent such that the second segment and the third segment are generally parallel to each other.
3. The medical device of claim 2 , wherein in the second flowering position, the left atrial appendage closure implant is partially disposed within the lumen of the delivery catheter such that the fourth bend is opened compared to the first constrained position, and the second segment is translated radially outward compared to the first constrained position.
4. The medical device of claim 3 , wherein in the third mid-deployment position, a proximal end of the second segment is translated radially outward and distally compared to the second flowering position.
5. The medical device of claim 4 , wherein in the third mid-deployment position, the first segment extends from the delivery catheter radially outward and distally toward the third bend, the second segment extends from the third bend radially inward and distally toward the fourth bend, and the third segment extends from the fourth bend proximally and radially inward toward the distal collar.
6. The medical device of claim 4 , wherein in the fourth unconstrained position, the left atrial appendage closure implant is disposed outside of the delivery catheter, the second bend defines a widest lateral extent of the left atrial appendage closure implant, the first segment extends from the second bend distally and radially inward toward the third bend, the second segment extends from the third bend radially inward and distally toward the fourth bend, and the third segment extends from the fourth bend proximally and radially inward toward the distal collar.
7. The medical device of claim 1 , wherein the support frame includes a plurality of anchors arranged in a first row of anchors and a second row of anchors such that the plurality of anchors forms a staggered pattern about a circumference of the left atrial appendage closure implant.
8. The medical device of claim 1 , further including a delivery shaft slidably disposed within the lumen of the delivery catheter, the delivery shaft having a distal end removably attached to the left atrial appendage closure implant at the proximal collar.
9. The medical device of claim 1 , wherein the left atrial appendage closure implant includes a membrane disposed over at least a portion of the support frame.
10. A left atrial appendage closure implant, comprising:
a self-expanding support frame having a circumference and a central longitudinal axis;
a membrane disposed over at least a portion of the support frame; and
a plurality of anchors arranged into a first row and a second row such that the first row and the second row form a staggered pattern about the circumference of the support frame.
11. The left atrial appendage closure implant of claim 10 , wherein at least some of the plurality of anchors project through the membrane.
12. The left atrial appendage closure implant of claim 10 , wherein the support frame includes a first bend adjacent a proximal collar, a second bend, a third bend, and a fourth bend adjacent a distal collar.
13. The left atrial appendage closure implant of claim 12 , wherein the support frame is actuatable between a first position, a second position, a third position, and a fourth position.
14. The left atrial appendage closure implant of claim 13 , wherein the support frame includes a plurality of struts forming a lattice of generally diamond-shaped wire portions.
15. The left atrial appendage closure implant of claim 14 , wherein the support frame includes at least a first row of generally diamond-shaped wire portions, a second row of generally diamond-shaped wire portions adjacent the first row, a third row of generally diamond-shaped wire portions adjacent the second row, and a fourth row of generally diamond-shaped wire portions adjacent the third row.
16. The left atrial appendage closure implant of claim 14 , wherein in the fourth position, at least a portion of the support frame extends distally of a distal end of the plurality of struts.
17. A method of manufacturing a left atrial appendage closure implant, comprising:
obtaining an elongate tubular member having a lumen extending therethrough and an annular ring member;
laser cutting the tubular member to form a proximal collar, a plurality of struts, a plurality of anchors interspersed among the plurality of struts, and a plurality of free distal ends;
forming the plurality of struts into a lattice of generally diamond-shaped wire portions;
fixedly attaching the plurality of free distal ends to the annular ring member;
positioning the plurality of struts such that a cross-sectional profile of the left atrial appendage closure implant in an unconstrained position includes a first bend extending radially outward from the proximal collar to a second bend, a first segment extending distally and radially inward from the second bend to a third bend, a second segment extending distally and radially inward from the third bend to a fourth bend, and a third segment extending proximally and radially inward from the fourth bend to the annular ring member; and
attaching a membrane over at least a portion of the plurality of struts such that the plurality of anchors extends through the membrane.
18. The method of claim 17 , wherein the annular ring member has an outer diameter that is smaller than an outer diameter of the elongate tubular member prior to laser cutting.
19. The method of claim 17 , wherein fixedly attaching the plurality of free ends to the annular ring member includes inserting the plurality of free distal ends into a distal end of the annular ring member.
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/057,573 US20140135817A1 (en) | 2012-11-14 | 2013-10-18 | Left atrial appendage closure implant |
EP13798490.2A EP2919660A1 (en) | 2012-11-14 | 2013-11-14 | Left atrial appendage closure implant |
CA2891491A CA2891491C (en) | 2012-11-14 | 2013-11-14 | Left atrial appendage closure implant |
PCT/US2013/070091 WO2014078531A1 (en) | 2012-11-14 | 2013-11-14 | Left atrial appendage closure implant |
CN201380070319.5A CN104918559B (en) | 2012-11-14 | 2013-11-14 | Left atrial appendage closure implant |
JP2015542775A JP2015534881A (en) | 2012-11-14 | 2013-11-14 | Left atrial appendage closure implant |
US15/493,736 US11241237B2 (en) | 2012-11-14 | 2017-04-21 | Left atrial appendage closure implant |
US17/564,547 US20220117608A1 (en) | 2012-11-14 | 2021-12-29 | Left atrial appendage closure implant |
US18/489,473 US20240065698A1 (en) | 2012-11-14 | 2023-10-18 | Left atrial appendage closure implant |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261726337P | 2012-11-14 | 2012-11-14 | |
US14/057,573 US20140135817A1 (en) | 2012-11-14 | 2013-10-18 | Left atrial appendage closure implant |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/493,736 Continuation US11241237B2 (en) | 2012-11-14 | 2017-04-21 | Left atrial appendage closure implant |
Publications (1)
Publication Number | Publication Date |
---|---|
US20140135817A1 true US20140135817A1 (en) | 2014-05-15 |
Family
ID=50682418
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/057,573 Abandoned US20140135817A1 (en) | 2012-11-14 | 2013-10-18 | Left atrial appendage closure implant |
US15/493,736 Active 2036-01-30 US11241237B2 (en) | 2012-11-14 | 2017-04-21 | Left atrial appendage closure implant |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/493,736 Active 2036-01-30 US11241237B2 (en) | 2012-11-14 | 2017-04-21 | Left atrial appendage closure implant |
Country Status (6)
Country | Link |
---|---|
US (2) | US20140135817A1 (en) |
EP (1) | EP2919660A1 (en) |
JP (1) | JP2015534881A (en) |
CN (1) | CN104918559B (en) |
CA (1) | CA2891491C (en) |
WO (1) | WO2014078531A1 (en) |
Cited By (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150105817A1 (en) * | 2008-05-02 | 2015-04-16 | Sequent Medical Inc. | Filamentary devices for treatment of vascular defects |
CN105054985A (en) * | 2015-07-28 | 2015-11-18 | 杭州德诺科技有限公司 | Improved left auricle occluder |
US9198670B2 (en) | 2013-08-16 | 2015-12-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US9259337B2 (en) | 2007-06-04 | 2016-02-16 | Sequent Medical, Inc. | Methods and devices for treatment of vascular defects |
WO2018053352A1 (en) * | 2016-09-16 | 2018-03-22 | Nsvascular, Inc. | Thin-film micromesh occlusion devices and related methods |
US9955976B2 (en) | 2013-08-16 | 2018-05-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
CN108024813A (en) * | 2015-07-13 | 2018-05-11 | 曼威医疗技术有限公司 | Method and apparatus for left atrial appendage occlusion |
EP3320861A1 (en) | 2016-11-15 | 2018-05-16 | Biotronik AG | Device for positioning and release of a closure implant for closing the left atrial auricle |
WO2018112276A1 (en) * | 2016-12-14 | 2018-06-21 | The Regents Of The University Of California | Flexible heart valve prosthesis |
CN108451569A (en) * | 2017-02-21 | 2018-08-28 | 科赫里克斯医疗股份有限公司 | Medical treatment device for correcting left auricle of heart and relevant system and method |
US20190008495A1 (en) * | 2015-12-31 | 2019-01-10 | Lifetech Scientific (Shenzhen) Co., Ltd. | Left atrial appendage occluder |
US20190125362A1 (en) * | 2017-10-27 | 2019-05-02 | Boston Scientific Scimed, Inc. | Occlusive medical device with cushioning member |
US10349947B2 (en) | 2015-02-18 | 2019-07-16 | Boston Scientific Scimed, Inc. | Vascular occlusion devices |
US10383725B2 (en) | 2016-08-11 | 2019-08-20 | 4C Medical Technologies, Inc. | Heart chamber prosthetic valve implant with base, mesh and dome sections with single chamber anchoring for preservation, supplementation and/or replacement of native valve function |
US10478194B2 (en) * | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
CN110960279A (en) * | 2018-09-29 | 2020-04-07 | 上海微创医疗器械(集团)有限公司 | Left auricle plugging device and left auricle plugging system |
US10682145B2 (en) | 2015-02-10 | 2020-06-16 | Boston Scientific Scimed, Inc. | Vascular occlusion devices |
US10758240B2 (en) | 2009-06-17 | 2020-09-01 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10758241B1 (en) | 2019-03-25 | 2020-09-01 | Laminar, Inc. | Devices, systems, and methods for treating the left atrial appendage |
US10765416B2 (en) * | 2015-12-31 | 2020-09-08 | Lifetech Scientific (Shenzhen) Co., Ltd | Left atrial appendage occluder |
US10772637B2 (en) | 2009-06-17 | 2020-09-15 | Coherex Medical, Inc. | Medical device and delivery system for modification of left atrial appendage and methods thereof |
US10820907B2 (en) | 2014-09-12 | 2020-11-03 | Carag Ag | Occluder |
US20210038230A1 (en) * | 2011-09-16 | 2021-02-11 | W. L. Gore & Associates, Inc. | Occlusive devices |
US10993803B2 (en) | 2011-04-01 | 2021-05-04 | W. L. Gore & Associates, Inc. | Elastomeric leaflet for prosthetic heart valves |
US11000289B2 (en) | 2009-06-17 | 2021-05-11 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US11129622B2 (en) | 2015-05-14 | 2021-09-28 | W. L. Gore & Associates, Inc. | Devices and methods for occlusion of an atrial appendage |
US11154303B2 (en) | 2007-10-19 | 2021-10-26 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US11173023B2 (en) | 2017-10-16 | 2021-11-16 | W. L. Gore & Associates, Inc. | Medical devices and anchors therefor |
US11234706B2 (en) | 2018-02-14 | 2022-02-01 | Boston Scientific Scimed, Inc. | Occlusive medical device |
US11291453B2 (en) | 2019-03-15 | 2022-04-05 | Sequent Medical, Inc. | Filamentary devices having a flexible joint for treatment of vascular defects |
US11317921B2 (en) | 2019-03-15 | 2022-05-03 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US11369355B2 (en) | 2019-06-17 | 2022-06-28 | Coherex Medical, Inc. | Medical device and system for occluding a tissue opening and method thereof |
US20220218356A1 (en) * | 2018-03-29 | 2022-07-14 | Boston Scientific Scimed, Inc. | Occlusive medical device with fixation members |
US11484320B2 (en) * | 2019-12-18 | 2022-11-01 | Boston Scientific Scimed, Inc. | Left atrial appendage closure device with anti-thrombogenic covering |
US11540837B2 (en) | 2009-06-17 | 2023-01-03 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
WO2023283440A1 (en) * | 2021-07-09 | 2023-01-12 | Boston Scientific Scimed, Inc. | Direct oral anticoagulant-eluting medical device |
WO2023283176A1 (en) * | 2021-07-08 | 2023-01-12 | Boston Scientific Scimedn, Inc. | Left atrial appendage closure device |
US11559309B2 (en) | 2019-03-15 | 2023-01-24 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US11678886B2 (en) | 2014-04-14 | 2023-06-20 | Microvention, Inc. | Devices for therapeutic vascular procedures |
US11717303B2 (en) | 2013-03-13 | 2023-08-08 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
US11786256B2 (en) | 2016-10-27 | 2023-10-17 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
US11812969B2 (en) | 2020-12-03 | 2023-11-14 | Coherex Medical, Inc. | Medical device and system for occluding a tissue opening and method thereof |
US11857441B2 (en) | 2018-09-04 | 2024-01-02 | 4C Medical Technologies, Inc. | Stent loading device |
US11911258B2 (en) | 2013-06-26 | 2024-02-27 | W. L. Gore & Associates, Inc. | Space filling devices |
US11918227B2 (en) | 2009-06-17 | 2024-03-05 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US11931253B2 (en) | 2020-01-31 | 2024-03-19 | 4C Medical Technologies, Inc. | Prosthetic heart valve delivery system: ball-slide attachment |
US11944537B2 (en) | 2017-01-24 | 2024-04-02 | 4C Medical Technologies, Inc. | Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10617425B2 (en) | 2014-03-10 | 2020-04-14 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
US11399842B2 (en) | 2013-03-13 | 2022-08-02 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
DE102013019890A1 (en) * | 2013-11-28 | 2015-05-28 | Bentley Innomed Gmbh | Medical implant |
CN105662516A (en) * | 2016-03-03 | 2016-06-15 | 上海普实医疗器械科技有限公司 | Left aurcle plugging device |
CN107198552B (en) * | 2016-03-18 | 2024-03-29 | 上海佐心医疗科技有限公司 | Left auricle plugging device |
CN106137299B (en) * | 2016-08-03 | 2019-12-13 | 南京友德邦医疗科技有限公司 | Plugging device for left auricle |
US11426172B2 (en) | 2016-10-27 | 2022-08-30 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
EP3614933A1 (en) * | 2017-04-27 | 2020-03-04 | Boston Scientific Scimed, Inc. | Occlusive medical device with fabric retention barb |
CN107126241B (en) * | 2017-06-16 | 2023-08-08 | 宁波迪创医疗科技有限公司 | Biological cavity anchoring device capable of being completely recovered and repeatedly released |
CN109419548A (en) * | 2017-08-21 | 2019-03-05 | 上海普实医疗器械科技有限公司 | Occluder for left auricle and its manufacturing method |
JP7013591B2 (en) * | 2017-12-18 | 2022-01-31 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Closure device with expandable members |
EP3787525A4 (en) * | 2018-05-02 | 2022-06-22 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
US11389284B2 (en) | 2018-09-28 | 2022-07-19 | Boston Scientific Scimed, Inc. | Embolic protection devices |
US20200253614A1 (en) | 2019-02-08 | 2020-08-13 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
CN110522486B (en) * | 2019-04-22 | 2021-04-09 | 上海佐心医疗科技有限公司 | Plugging bracket for left auricle |
CN114617603B (en) * | 2020-12-10 | 2024-04-02 | 先健科技(深圳)有限公司 | Plugging device |
CN112274208B (en) * | 2020-12-29 | 2021-05-25 | 北京泰杰伟业科技有限公司 | Auxiliary support in tumor |
WO2022222256A1 (en) * | 2021-04-21 | 2022-10-27 | 上海苏畅医疗科技有限公司 | Aneurysm occlusion device and preparation method therefor |
WO2023018697A1 (en) | 2021-08-13 | 2023-02-16 | Boston Scientific Scimed, Inc. | Left atrial appendage implant with distal engagement element |
WO2023154428A1 (en) | 2022-02-11 | 2023-08-17 | Boston Scientific Scimed, Inc. | Implantable medical device with opposing barbs for bi-directional stability |
US20230346384A1 (en) | 2022-04-27 | 2023-11-02 | Boston Scientific Scimed, Inc. | Left atrial appendage closure device with central support |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5375612A (en) * | 1992-04-07 | 1994-12-27 | B. Braun Celsa | Possibly absorbable blood filter |
US20110054515A1 (en) * | 2009-08-25 | 2011-03-03 | John Bridgeman | Device and method for occluding the left atrial appendage |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6168622B1 (en) * | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
US7044134B2 (en) * | 1999-11-08 | 2006-05-16 | Ev3 Sunnyvale, Inc | Method of implanting a device in the left atrial appendage |
US6689150B1 (en) | 1999-10-27 | 2004-02-10 | Atritech, Inc. | Filter apparatus for ostium of left atrial appendage |
EP1469790B1 (en) * | 2002-01-25 | 2016-10-19 | Atritech, Inc. | Atrial appendage blood filtration systems |
US20030176884A1 (en) * | 2002-03-12 | 2003-09-18 | Marwane Berrada | Everted filter device |
WO2006026744A1 (en) * | 2004-08-31 | 2006-03-09 | Cook Incorporated | Device for treating an aneurysm |
US7972359B2 (en) | 2005-09-16 | 2011-07-05 | Atritech, Inc. | Intracardiac cage and method of delivering same |
US9034006B2 (en) * | 2005-12-01 | 2015-05-19 | Atritech, Inc. | Method and apparatus for retrieving an embolized implant |
US20090171386A1 (en) * | 2007-12-28 | 2009-07-02 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US20110301630A1 (en) * | 2010-06-02 | 2011-12-08 | Cook Incorporated | Occlusion device |
-
2013
- 2013-10-18 US US14/057,573 patent/US20140135817A1/en not_active Abandoned
- 2013-11-14 CN CN201380070319.5A patent/CN104918559B/en active Active
- 2013-11-14 CA CA2891491A patent/CA2891491C/en not_active Expired - Fee Related
- 2013-11-14 EP EP13798490.2A patent/EP2919660A1/en active Pending
- 2013-11-14 WO PCT/US2013/070091 patent/WO2014078531A1/en active Application Filing
- 2013-11-14 JP JP2015542775A patent/JP2015534881A/en active Pending
-
2017
- 2017-04-21 US US15/493,736 patent/US11241237B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5375612A (en) * | 1992-04-07 | 1994-12-27 | B. Braun Celsa | Possibly absorbable blood filter |
US20110054515A1 (en) * | 2009-08-25 | 2011-03-03 | John Bridgeman | Device and method for occluding the left atrial appendage |
Cited By (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11179159B2 (en) | 2007-06-04 | 2021-11-23 | Sequent Medical, Inc. | Methods and devices for treatment of vascular defects |
US9259337B2 (en) | 2007-06-04 | 2016-02-16 | Sequent Medical, Inc. | Methods and devices for treatment of vascular defects |
US11154303B2 (en) | 2007-10-19 | 2021-10-26 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US20150105817A1 (en) * | 2008-05-02 | 2015-04-16 | Sequent Medical Inc. | Filamentary devices for treatment of vascular defects |
US20150150563A1 (en) * | 2008-05-02 | 2015-06-04 | Sequent Medical Inc. | Filamentary devices for treatment of vascular defects |
US10610231B2 (en) | 2008-05-02 | 2020-04-07 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US9597087B2 (en) | 2008-05-02 | 2017-03-21 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US11540837B2 (en) | 2009-06-17 | 2023-01-03 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10772637B2 (en) | 2009-06-17 | 2020-09-15 | Coherex Medical, Inc. | Medical device and delivery system for modification of left atrial appendage and methods thereof |
US11000289B2 (en) | 2009-06-17 | 2021-05-11 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10758240B2 (en) | 2009-06-17 | 2020-09-01 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US11253262B2 (en) | 2009-06-17 | 2022-02-22 | Coherex Medical, Inc. | Delivery device, system, and method thereof |
US11918227B2 (en) | 2009-06-17 | 2024-03-05 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10993803B2 (en) | 2011-04-01 | 2021-05-04 | W. L. Gore & Associates, Inc. | Elastomeric leaflet for prosthetic heart valves |
US11457925B2 (en) | 2011-09-16 | 2022-10-04 | W. L. Gore & Associates, Inc. | Occlusive devices |
US20210038230A1 (en) * | 2011-09-16 | 2021-02-11 | W. L. Gore & Associates, Inc. | Occlusive devices |
US11717303B2 (en) | 2013-03-13 | 2023-08-08 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
US11911258B2 (en) | 2013-06-26 | 2024-02-27 | W. L. Gore & Associates, Inc. | Space filling devices |
US10136896B2 (en) | 2013-08-16 | 2018-11-27 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US9492174B2 (en) | 2013-08-16 | 2016-11-15 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US9955976B2 (en) | 2013-08-16 | 2018-05-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US9198670B2 (en) | 2013-08-16 | 2015-12-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US10939914B2 (en) | 2013-08-16 | 2021-03-09 | Sequent Medical, Inc. | Filamentary devices for the treatment of vascular defects |
US10813645B2 (en) | 2013-08-16 | 2020-10-27 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US11723667B2 (en) | 2013-08-16 | 2023-08-15 | Microvention, Inc. | Filamentary devices for treatment of vascular defects |
US11678886B2 (en) | 2014-04-14 | 2023-06-20 | Microvention, Inc. | Devices for therapeutic vascular procedures |
US10820907B2 (en) | 2014-09-12 | 2020-11-03 | Carag Ag | Occluder |
US10682145B2 (en) | 2015-02-10 | 2020-06-16 | Boston Scientific Scimed, Inc. | Vascular occlusion devices |
US10349947B2 (en) | 2015-02-18 | 2019-07-16 | Boston Scientific Scimed, Inc. | Vascular occlusion devices |
CN113040854A (en) * | 2015-04-16 | 2021-06-29 | 科赫里克斯医疗股份有限公司 | Medical device for modifying left atrial appendage and related systems and methods |
US11129622B2 (en) | 2015-05-14 | 2021-09-28 | W. L. Gore & Associates, Inc. | Devices and methods for occlusion of an atrial appendage |
US11826052B2 (en) | 2015-05-14 | 2023-11-28 | W. L. Gore & Associates, Inc. | Devices and methods for occlusion of an atrial appendage |
CN108024813A (en) * | 2015-07-13 | 2018-05-11 | 曼威医疗技术有限公司 | Method and apparatus for left atrial appendage occlusion |
US10792045B2 (en) | 2015-07-28 | 2020-10-06 | Hangzhou Nuomao Medtech Co., Ltd. | Left atrial appendage occluder |
CN105054985A (en) * | 2015-07-28 | 2015-11-18 | 杭州德诺科技有限公司 | Improved left auricle occluder |
US10478194B2 (en) * | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
US11357510B2 (en) | 2015-09-23 | 2022-06-14 | Covidien Lp | Occlusive devices |
US10765416B2 (en) * | 2015-12-31 | 2020-09-08 | Lifetech Scientific (Shenzhen) Co., Ltd | Left atrial appendage occluder |
US11253241B2 (en) * | 2015-12-31 | 2022-02-22 | Lifetech Scientific (Shenzhen) Co., Ltd. | Left atrial appendage occluder |
US20190008495A1 (en) * | 2015-12-31 | 2019-01-10 | Lifetech Scientific (Shenzhen) Co., Ltd. | Left atrial appendage occluder |
US10751169B2 (en) | 2016-08-11 | 2020-08-25 | 4C Medical Technologies, Inc. | Heart chamber prosthetic valve implant with base, mesh and dome sections with single chamber anchoring for preservation, supplementation and/or replacement of native valve function |
US10828152B2 (en) | 2016-08-11 | 2020-11-10 | 4C Medical Technologies, Inc. | Heart chamber prosthetic valve implant with base, spring and dome sections with single chamber anchoring for preservation, supplementation and/or replacement of native valve function |
US11026782B2 (en) | 2016-08-11 | 2021-06-08 | 4C Medical Technologies, Inc. | Heart chamber prosthetic valve implant with elevated valve section and single chamber anchoring for preservation, supplementation and/or replacement of native valve function |
US10383725B2 (en) | 2016-08-11 | 2019-08-20 | 4C Medical Technologies, Inc. | Heart chamber prosthetic valve implant with base, mesh and dome sections with single chamber anchoring for preservation, supplementation and/or replacement of native valve function |
WO2018053352A1 (en) * | 2016-09-16 | 2018-03-22 | Nsvascular, Inc. | Thin-film micromesh occlusion devices and related methods |
US11786256B2 (en) | 2016-10-27 | 2023-10-17 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
EP3320861A1 (en) | 2016-11-15 | 2018-05-16 | Biotronik AG | Device for positioning and release of a closure implant for closing the left atrial auricle |
US10660647B2 (en) | 2016-11-15 | 2020-05-26 | Biotronik Ag | Device for positioning and releasing a closure implant for closing the left atrial appendage |
WO2018112276A1 (en) * | 2016-12-14 | 2018-06-21 | The Regents Of The University Of California | Flexible heart valve prosthesis |
US11944537B2 (en) | 2017-01-24 | 2024-04-02 | 4C Medical Technologies, Inc. | Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve |
EP3372173A3 (en) * | 2017-02-21 | 2018-12-26 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
EP3685768A1 (en) * | 2017-02-21 | 2020-07-29 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems |
CN108451569A (en) * | 2017-02-21 | 2018-08-28 | 科赫里克斯医疗股份有限公司 | Medical treatment device for correcting left auricle of heart and relevant system and method |
US11173023B2 (en) | 2017-10-16 | 2021-11-16 | W. L. Gore & Associates, Inc. | Medical devices and anchors therefor |
US11020123B2 (en) * | 2017-10-27 | 2021-06-01 | Boston Scientific Scimed, Inc. | Occlusive medical device with cushioning member |
US20190125362A1 (en) * | 2017-10-27 | 2019-05-02 | Boston Scientific Scimed, Inc. | Occlusive medical device with cushioning member |
US11234706B2 (en) | 2018-02-14 | 2022-02-01 | Boston Scientific Scimed, Inc. | Occlusive medical device |
US20220218356A1 (en) * | 2018-03-29 | 2022-07-14 | Boston Scientific Scimed, Inc. | Occlusive medical device with fixation members |
US11857441B2 (en) | 2018-09-04 | 2024-01-02 | 4C Medical Technologies, Inc. | Stent loading device |
CN110960279A (en) * | 2018-09-29 | 2020-04-07 | 上海微创医疗器械(集团)有限公司 | Left auricle plugging device and left auricle plugging system |
US11559309B2 (en) | 2019-03-15 | 2023-01-24 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US11317921B2 (en) | 2019-03-15 | 2022-05-03 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US11291453B2 (en) | 2019-03-15 | 2022-04-05 | Sequent Medical, Inc. | Filamentary devices having a flexible joint for treatment of vascular defects |
US11219462B2 (en) | 2019-03-25 | 2022-01-11 | Laminar, Inc. | Devices, systems, and methods for treating the left atrial appendage |
US11399843B2 (en) | 2019-03-25 | 2022-08-02 | Laminar, Inc. | Devices, systems, and methods for treating the left atrial appendage |
US11123080B2 (en) | 2019-03-25 | 2021-09-21 | Laminar, Inc. | Devices, systems, and methods for treating the left atrial appendage |
US10758241B1 (en) | 2019-03-25 | 2020-09-01 | Laminar, Inc. | Devices, systems, and methods for treating the left atrial appendage |
US11369355B2 (en) | 2019-06-17 | 2022-06-28 | Coherex Medical, Inc. | Medical device and system for occluding a tissue opening and method thereof |
US11484320B2 (en) * | 2019-12-18 | 2022-11-01 | Boston Scientific Scimed, Inc. | Left atrial appendage closure device with anti-thrombogenic covering |
US11931253B2 (en) | 2020-01-31 | 2024-03-19 | 4C Medical Technologies, Inc. | Prosthetic heart valve delivery system: ball-slide attachment |
US11812969B2 (en) | 2020-12-03 | 2023-11-14 | Coherex Medical, Inc. | Medical device and system for occluding a tissue opening and method thereof |
WO2023283176A1 (en) * | 2021-07-08 | 2023-01-12 | Boston Scientific Scimedn, Inc. | Left atrial appendage closure device |
WO2023283440A1 (en) * | 2021-07-09 | 2023-01-12 | Boston Scientific Scimed, Inc. | Direct oral anticoagulant-eluting medical device |
Also Published As
Publication number | Publication date |
---|---|
CA2891491C (en) | 2019-08-20 |
CN104918559B (en) | 2020-02-14 |
JP2015534881A (en) | 2015-12-07 |
EP2919660A1 (en) | 2015-09-23 |
CA2891491A1 (en) | 2014-05-22 |
US11241237B2 (en) | 2022-02-08 |
WO2014078531A1 (en) | 2014-05-22 |
US20170224354A1 (en) | 2017-08-10 |
CN104918559A (en) | 2015-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11241237B2 (en) | Left atrial appendage closure implant | |
US11413047B2 (en) | Occlusive medical implant | |
US10603020B2 (en) | Centered balloon for the left atrial appendage | |
US20240065698A1 (en) | Left atrial appendage closure implant | |
US20150342718A1 (en) | Expanding distal sheath with combined embolic protection | |
EP3733095B1 (en) | Left atrial appendage implant | |
US11432809B2 (en) | Occlusive medical device with fabric retention barb | |
US20230218414A1 (en) | Projecting member with barb for cardiovascular devices | |
US20200281708A1 (en) | Systems and methods for protecting the cerebral vasculature | |
JP7241095B2 (en) | Occlusive medical device with charged polymer coating | |
US20180055496A1 (en) | Jugular access left atrial appendage closure device | |
US20230048873A1 (en) | Left Atrial Appendage Implant with Distal Engagement Element |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TISCHLER, BRIAN J.;CLARK, CHRISTOPHER J.;PEIFFER, DENNIS A.;AND OTHERS;REEL/FRAME:031437/0046 Effective date: 20130903 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |